Inocor (inamrinone) is a small molecule pharmaceutical. Inamrinone was first approved as Inocor on 1984-07-31. It is used to treat cardiogenic shock, dilated cardiomyopathy, heart failure, and low cardiac output in the USA. The pharmaceutical is active against cGMP-inhibited 3',5'-cyclic phosphodiesterase A and cGMP-inhibited 3',5'-cyclic phosphodiesterase B.
|Indication||cardiogenic shock, dilated cardiomyopathy, heart failure, low cardiac output|
|Drug Class||Cardiotonics (amrinone type)|